Octapharma’s ongoing dedication to improving the lives of people with haemophilia and von Willebrand disease to be showcased at the ISTH 2021 Congress

Octapharma announced that new clinical and scientific findings encompassing their Haematology portfolio, including Nuwiq®, wilate®, octanate® and octanine®F, will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) Virtual Congress, taking place on July 17–21, 2021.
Read more
The Next Breakthrough in Precision Medicine: OMICs-Based Approaches and Computational Work The Next Breakthrough in Precision Medicine: OMICs-Based Approaches and Computational Work

The Next Breakthrough in Precision Medicine: OMICs-Based Approaches and Computational Work

Despite remarkable scientific advances and the plethora of scientific information collected in medicine, specific and targeted therapies remain challenging. The study of most disease processes occurs after manifestation of symptoms, which limits innovation of interventions to halt disease progression.
Read more
RSS
12345678